Theravance Biopharma, Inc. (TBPH)
13.58
-0.08
(-0.62%)
USD |
NASDAQ |
Mar 05, 16:00
13.61
+0.03
(+0.22%)
Pre-Market: 20:00
Theravance Biopharma Price : 13.58 for March 5, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Integer Holdings Corp. | 85.23 |
| QuidelOrtho Corp. | 21.41 |
| Corcept Therapeutics, Inc. | 34.04 |
| Nektar Therapeutics | 72.45 |
| Innoviva, Inc. | 22.18 |
Price Related Metrics
| PE Ratio | 24.14 |
| PS Ratio | 8.522 |
| Price to Book Value | 2.957 |
| Price to Free Cash Flow | 2.812 |
| Earnings Yield | 4.14% |
| Market Cap | 688.13M |
| Normalized PE Ratio | 24.14 |